Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand

Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand

Background: The COVID-19 pandemic has evolved quickly, with variants of concern resulting in the need to offer booster vaccinations. Unfortunately, the booster uptake has been slow and vaccine response has shown to wane over time. Therefore, it's critical to evaluate the role of vaccinations on...

Full description

Bibliographic Details
Main Authors: Kannikar Intawong, Suwat Chariyalertsak, Kittipan Chalom, Thanachol Wonghirundecha, Woravut Kowatcharakul, Aksara Thongprachum, Narain Chotirosniramit, Kajohnsak Noppakun, Krit Khwanngern, Worachet Teacharak, Prapon Piamanant, Pimpinan Khammawan, Sopon Iamsirithaworng
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
COVID-19
SARS-CoV-2
Mortality
COVID-19 vaccines
SARS-CoV-2 omicron subvariant
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118223001925

Internet

http://www.sciencedirect.com/science/article/pii/S1684118223001925

Similar Items